News/ Pharma Market Access/ Sales and Marketing/ UK & Europe Biosimilars don’t need big market share to bring savings – IMS Richard Staines AbbVie, biosimilar, IMS, pricing, Sandoz 0 Comment Competition can also drive down price of entire drug class. Share X Biosimilars don’t need big market share to bring savings – IMS https://pharmaphorum.com/news/biosimilars-dont-need-big-market-share-to-bring-savings-ims/